George Magrath

CIK: 0001999390

Transaction Breakdown

Open Market Buys (P)3 (20.0%)

High conviction signal

Open Market Sales (S)4 (26.7%)

Position reduction

Option Exercises (M)1 (6.7%)

Derivative conversions

Awards (A)4 (26.7%)

Compensation grants

Other (G, F, J, C, D, …)3 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IRD

Opus Genetics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (15 total)

IRD
Opus Genetics, Inc.
Oct 23, 2026
Sale(S)
Direct
9.6K shares at avg. $3.58$34K
IRD
Opus Genetics, Inc.
Sep 9, 2026
Exercise(M)
Direct
392.2K shares at avg. $1.15$451K
IRD
Opus Genetics, Inc.
Sep 9, 2026
Tax Payment(F)
Direct
75.5K shares at avg. $5.97$451K
IRD
Opus Genetics, Inc.
Jul 23, 2026
Sale(S)
Direct
9.5K shares at avg. $2.95$28K
IRD
Opus Genetics, Inc.
Apr 23, 2026
Sale(S)
Direct
9.5K shares at avg. $5.22$50K
IRD
Opus Genetics, Inc.
Mar 16, 2026
Sale(S)
Direct
24.4K shares at avg. $5.21$127K
IRD
Opus Genetics, Inc.
Jan 22, 2026
Award(A)
Direct
483.6K shares-
IRD
Opus Genetics, Inc.
Nov 1, 2025
Tax Payment(F)
Direct
30.4K shares at avg. $2.30$70K
IRD
Opus Genetics, Inc.
Mar 24, 2025
Award(A)
Direct
392.2K shares-
IRD
Opus Genetics, Inc.
Mar 13, 2025
Award(A)
Direct
330.7K shares-
IRD
Opus Genetics, Inc.
Dec 26, 2024
Purchase(P)
Direct
100K shares at avg. $0.98$98K
IRD
Opus Genetics, Inc.
Dec 23, 2024
Award(A)
Direct
6.2K shares-
IRD
Opus Genetics, Inc.
Nov 18, 2024
Purchase(P)
Direct
9.7K shares at avg. $1.02$10K
IRD
Opus Genetics, Inc.
Nov 15, 2024
Purchase(P)
Direct
90.3K shares at avg. $1.01$91K
IRD
Opus Genetics, Inc.
Nov 1, 2024
Tax Payment(F)
Direct
37.1K shares at avg. $1.18$44K

		Type	Shares	Price		Ownership
Oct 23, 2026	IRD Opus Genetics, Inc.	Sale(S)	9,591	$3.58	$34,384	Direct
Sep 9, 2026	IRD Opus Genetics, Inc.	Exercise(M)	392,157	$1.15	$450,981	Direct
Sep 9, 2026	IRD Opus Genetics, Inc.	Tax Payment(F)	75,541	$5.97	$450,980	Direct
Jul 23, 2026	IRD Opus Genetics, Inc.	Sale(S)	9,475	$2.95	$27,926	Direct
Apr 23, 2026	IRD Opus Genetics, Inc.	Sale(S)	9,511	$5.22	$49,647	Direct
Mar 16, 2026	IRD Opus Genetics, Inc.	Sale(S)	24,438	$5.21	$127,327	Direct
Jan 22, 2026	IRD Opus Genetics, Inc.	Award(A)	483,639	-	$0	Direct
Nov 1, 2025	IRD Opus Genetics, Inc.	Tax Payment(F)	30,350	$2.30	$69,805	Direct
Mar 24, 2025	IRD Opus Genetics, Inc.	Award(A)	392,157	-	-	Direct
Mar 13, 2025	IRD Opus Genetics, Inc.	Award(A)	330,697	-	-	Direct
Dec 26, 2024	IRD Opus Genetics, Inc.	Purchase(P)	100,000	$0.98	$97,600	Direct
Dec 23, 2024	IRD Opus Genetics, Inc.	Award(A)	6,200	-	$0	Direct
Nov 18, 2024	IRD Opus Genetics, Inc.	Purchase(P)	9,706	$1.02	$9,943	Direct
Nov 15, 2024	IRD Opus Genetics, Inc.	Purchase(P)	90,294	$1.01	$91,215	Direct
Nov 1, 2024	IRD Opus Genetics, Inc.	Tax Payment(F)	37,050	$1.18	$43,719	Direct

1-15 of 15 transactions

About Magrath George

Magrath George (SEC CIK 0001999390) files insider reports with the SEC as Chief Executive Officer of Opus Genetics, Inc. (IRD).

Signal8 holds 14 ownership filings by Magrath George, all Form 4s, filed between Nov 5, 2024 and Oct 27, 2026. Those filings report 15 transactions, from Nov 1, 2024 to Oct 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Magrath George's filings is in DURHAM, NC.

Recent filings by Magrath George

Oct 23, 2026: Open-market sale of IRD shares (Form 4, code S).
Sep 9, 2026: Option exercise of IRD shares (Form 4, code M).
Sep 9, 2026: Tax withholding of IRD shares (Form 4, code F).
Jul 23, 2026: Open-market sale of IRD shares (Form 4, code S).
Apr 23, 2026: Open-market sale of IRD shares (Form 4, code S).

Other insiders filing for Opus Genetics, Inc. (IRD)

SCHACHLE JOSEPH K, Chief Operating Officer
YERXA BENJAMIN R, President
Gagnon Robert E., Chief Financial Officer
Foundation Fighting Blindness Retinal Degeneration Fund, Director
Gallagher Cam, Director
Zaremba Rabourn Amy, Head of Fin. Quality Assurance

How to read Form 4 transaction codes